Gam Holding Ag Charles River Laboratories International, Inc. Transaction History

Gam Holding Ag

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 06, 2020	SELL	$126.05 - $152.76 $337,940 - $409,549	-2,681 Closed	0 $0
Q3 2019 Nov 08, 2019	SELL	$125.07 - $143.67 $406,352 - $466,783	-3,249 Reduced 54.79%	2,681 $355,000
Q2 2019 Aug 12, 2019	BUY	$123.4 - $148.55 $62,810 - $75,611	509 Added 9.39%	5,930 $841,000
Q1 2019 May 10, 2019	BUY	$104.82 - $146.73 $219,597 - $307,399	2,095 Added 62.99%	5,421 $787,000
Q4 2018 Feb 08, 2019	SELL	$105.09 - $137.23 $68,728 - $89,748	-654 Reduced 16.43%	3,326 $372,000
Q3 2018 Nov 13, 2018	BUY	$112.11 - $134.54 $126,011 - $151,222	1,124 Added 39.36%	3,980 $535,000
Q2 2018 Aug 09, 2018	SELL	$102.37 - $117.25 $312,023 - $357,378	-3,048 Reduced 51.63%	2,856 $321,000
Q1 2018 May 15, 2018	SELL	$98.19 - $115.2 $1.16 Million - $1.36 Million	-11,786 Reduced 66.63%	5,904 $630,000
Q4 2017 Feb 14, 2018	BUY	$100.43 - $118.09 $1.78 Million - $2.09 Million	17,690	17,690 $1.94 Million

730

51.8M

233K

236K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.7B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Gam Holding Ag, based on Form 13F filings with the SEC.

Stay updated on Gam Holding Ag with notifications on news.